Cannabis News Box

Biotechnology company slammed with $881 million synthetic cannabinoid lawsuit

Biotechnology company slammed with $881 million synthetic cannabinoid lawsuit

Bethan Rose Jenkins, Cannabis News Writer/Editorial

September 28, 2020

In March 2019, a $300 million joint business partnership was struck between Amyris and LAVVAN for the development of synthetic cannabinoids. The research, collaboration and license agreement has taken an unexpected turn year just one year and six months later, with California-based Amyris facing an ...

synthetic cannabinoid lawsuit